IRulya Therapeutics Inc.
Public company- Headquarters
- NEW HAVEN, Connecticut
- Industry
- Biotechnology
- Ticker
- IRLA
- CIK
- 0001662774
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
14
7 appointments, 7 departures
Last event
Oct 9, 2026
Executive departureCEO departs: Dirk Thye, M.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEODirk Thye, M.D. | Oct 9, 2026 | Departed |
| COOBrendan Hannah | Oct 9, 2026 | Departed |
| CFOJohn Militello, CPA | Oct 9, 2026 | Appointed |
| directorJune Bray | Oct 9, 2026 | Departed |
| Class I director and as a member of the Audit Committee and Compensation CommitteeCatherine M. Bonuccelli | Oct 9, 2026 | Appointed |
| Class III director and as chair of the Audit Committee and as chair of the Compensation CommitteeLeone Patterson | Oct 9, 2026 | Appointed |
| Class I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance CommitteeJames Valentine | Oct 9, 2026 | Appointed |
| Class II director and as a member of the Nominating and Corporate Governance CommitteeDrayton Wise | Oct 9, 2026 | Appointed |
| PresidentCharles Ryan | Sep 14, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
No events of this type on record.
Show all eventsLast verified Nov 8, 2026